• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Hua-Zhuo-Kai-Yu decoction inhibits apoptosis in nonalcoholic fatty liver disease

    2021-12-04 06:54:46YuTingLiHuanTianCuiLuYangLuLuJinYuMingWangXueQianDongWeiBoWenHongWuWangZhaiYiZhang
    Traditional Medicine Research 2021年1期

    Yu-Ting Li, Huan-Tian Cui, Lu Yang, Lu-Lu Jin, Yu-Ming Wang, Xue-Qian Dong, Wei-Bo Wen, Hong-Wu Wang,Zhai-Yi Zhang

    1College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China;2Shandong Provincial Key Laboratory of Animal Cell and Developmental Biology, School of Life Sciences, Shandong University, Qingdao 250100, China; 3Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin 301617,China; 4Department of Endocrinology in Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming 650021,China; 5College of Integrated Chinese and Western Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617,China.

    Abstract

    Background:Hua-Zhuo-Kai-Yu decoction(HZKY)is an empirical formula in traditional Chinese medicine that is derived from the classic ancient prescription Da-Chai-Hu decoction.It has been demonstrated to have good clinical effects on nonalcoholic fatty liver disease (NAFLD).However, the mechanism by which HZKY acts on NAFLD remains unclear.In this study,network pharmacology was used to predict the potential targets of HZKY in NAFLD.Additionally, in vivo studies were conducted to validate the crucial pathways determined using network pharmacology.Methods: Active compounds in HZKY were screened using the Traditional Chinese Medicine Systems Pharmacology and Analysis Platform and Traditional Chinese Medicine Integrated Database, and the potential targets of compounds in HZKY were predicted using Traditional Chinese Medicine Systems Pharmacology and Analysis Platform, Traditional Chinese Medicine Integrated Database, Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine, and PUBCHEM.In addition,targets involved in NAFLD were obtained from the GeneCards and Online Mendelian Inheritance in Man databases,and the potential targets of HZKY in NAFLD were identified based on the common potential targets between HZKY and NAFLD.Cytoscape 3.7.2 was used to visualize crosstalk and identify the key genes from the potential targets of HZKY in NAFLD.Kyoto Encyclopedia of Genes and Genomes analysis was conducted to predict the pathways by which HZKY acts on NAFLD.Rats were fed with a high-fat diet for 12 weeks to induce NAFLD and were then orally administered HZKY.Serum lipid levels and hematoxylin and eosin and oil red O staining results were assessed to determine the effects of HZKY in NALFD.Furthermore, the mechanisms of action of HZKY in NAFLD, as determined using network pharmacology, were validated based on the inhibition of apoptosis in the liver using Western blotting.Results:A total of 269 potential targets of 130 active compounds in HZKY were identified(oral bioavailability ≥30% and drug-like ≥0.18), and 62 targets were selected after being compared with the targets of NAFLD.Bcl-2-associated X protein (BAX), caspase3 (CASP3), and caspase9 (CASP9) were the key genes with the highest values of network connectivity.In addition, 45 Kyoto Encyclopedia of Genes and Genomes pathways,including apoptosis, fatty acid synthesis, and estrogen signaling, were enriched according to the selected genes of HZKY.In vivo studies showed that the serum levels of total cholesterol, triglyceride, and low-density lipoprotein cholesterol were significantly elevated and the serum level of high-density lipoprotein cholesterol was decreased in the model group compared with those in the control group(P <0.01 for all).The expressions of BAX,CASP9,and CASP3 were upregulated in the model group compared with those in the control group(P <0.05,P <0.01,and P <0.01, respectively), while HZKY treatment decreased the body weights and serum levels of total cholesterol,triglyceride, and low-density lipoprotein cholesterol and increased the serum levels of high-density lipoprotein cholesterol in NAFLD model rats(P <0.05,P <0.01,P <0.05,and P <0.05,respectively).Hematoxylin and eosin and oil red O staining indicated that HZKY treatment reduced steatosis in the hepatocytes.Moreover, HZKY treatment inhibited apoptosis in the liver by downregulating the expressions of BAX, CASP3, and CASP9 (P <0.05, P <0.01,and P <0.05,respectively).Conclusion:Our study demonstrates that HZKY improves NAFLD by inhibiting apoptosis in the liver by reducing the levels of BAX,CASP3,and CASP9.

    Key words:Network pharmacology,Hua-Zhuo-Kai-Yu decoction,Nonalcoholic fatty liver disease,Apoptosis

    Backgro und

    Nonalcoholic fatty liver disease(NAFLD)is caused by metabolic liver injury accompanied by extensive hepatic steatosis.Epidemiological studies have indicated that the morbidity of NAFLD is approximately 6.3%-45% in adults and 15% in developed areas such as Beijing, Shanghai, and Guangzhou in China [1, 2].Long-term NAFLD can cause chronic metabolic diseases such as diabetes,liver fibrosis, liver cirrhosis, and hepatocellular carcinoma [3, 4].Currently, clinical treatment for NAFLD includes administration of insulin sensitizers,antioxidants, and lipid-lowering drugs.However, these drugs have been shown to have multiple side effects.Lipid-lowering drugs can trigger the dysfunction of hepatic enzymes [5].Insulin sensitizers and antioxidants have been shown to induce water-sodium retention and increase the risk of cardiac diseases[6].

    Traditional Chinese medicine (TCM) has been demonstrated to have better treatment effects on NAFLD.Ling-Gui-Zhu-Gan decoction, which is a classic ancient TCM prescription, can attenuate high-fat diet (HFD)-induced NAFLD by improving insulin resistance (IR) and regulating lipid metabolism-related pathways [7].The empirical formula of the TCM Huo-Xue-Xiao-Zhi decoction can decrease tumor necrosis factor-α, transforming growth factor, and free fatty acid levels and improve hepatic function in patients with NAFLD [8].Additionally, the empirical formula of the TCM Yi-Qi-Huo-Xue-Qu-Tan can modulate the dysfunction of lipid metabolism in these patients[9].

    The classic ancient prescription Da-Chai-Hu (DCH)decoction (Chaihu (Bupleuri Radix), Huangqin(Scutellariae Radix), Shaoyao (Paeoniae Radix Alba),Banxia (Pinelliae Rhizoma), Shengjiang (Zingiberis Rhizoma Recens),Zhishi(Aurantii Fructus Immaturus),Dazao (Jujubae Fructus)) is described in the ancient book on Chinese medicine titledShanghan Zabing Lun(Treatise on Cold Damage Diseases,25 C.E.-220 C.E.), written by Zhang Zhongjing.According to the book,DCH is used to treat diseases of the liver,gallbladder, and pancreas.Recent studies have also demonstrated the hepatoprotective, cholagogue,anti-inflammatory, and lipid-lowering effects of DCH[10, 11].In addition, clinical studies have shown that DCH improves dyslipidemia in patients with NAFLD[12].Hua-Zhuo-Kai-Yu (HZKY) decoction, derived from a modification of DCH, was established by Doctor Wang Hongwu at the Tianjin University of Traditional Chinese Medicine.It has shown obvious clinical effects on NAFLD.However, the mechanisms of action of HZKY in NAFLD remain unknown.

    Network pharmacology, developed by Hopkins AL in England, is the study of the relationships among drugs, diseases, genes, and targets based on the combination of subject theory, including systematic biology, pharmacology, and multiple “omics” studies such as genomics and proteomics [13-16].The application of network pharmacology in studying the mechanisms of TCM is in line with the characteristics of TCM, including a systematic and holistic perspective with multiple components.It is developing into an effective tool for identifying the overall mechanisms of TCM drugs[17].In this study,network pharmacology was used to predict the potential targets of HZKY in NAFLD.Furthermore, rats were fed with HFD for 12 weeks to induce NAFLD and were then administered HZKY orally.Serum lipid levels and hematoxylin and eosin (H&E) and oil red O staining results were assessed to observe the effects of HZKY in NALFD.Moreover, the mechanisms of action of HZKY in NAFLD, as determined using network pharmacology, were validated using Western blotting,which showed apoptosis inhibition in the liver.

    Materials and Methods

    Network Pharmacology Study

    Identification of the main active compounds.HZKY is composed of Chaihu 12 g (Bupleuri Radix),Huangqin 9 g (Scutellariae Radix), Shaoyao 9 g(Paeoniae Radix Rubra), Zhishi 9 g (Aurantii Fructus Immaturus), Banxia 9 g (Pinelliae Rhizoma), Dahuang 6 g (Rhei Radix et Rhizoma), Bohe 9 g (Menthae Haplocalycis Herba), Heye 9 g (Nelumbinis Folium),and Peilan 9 g (Eupatorii Herba).The main compounds in HZKY were screened using the Traditional Chinese Medicine Systems Pharmacology and Analysis Platform (TCMSP)(http://tcmspw.com/tcmsp.php) and Traditional Chinese Medicine Integrated Database (TCMID)(http://www.megabionet.org/tcmid).The repeated compounds were counted only once.

    Because of the oral administration of HZKY for the treatment of NAFLD, oral bioavailability (OB) was regarded as the pharmacokinetic parameter for HZKY to be considered in the network pharmacology evaluations.The compounds in HZKY (OB ≥30%),which were considered to be absorbed, metabolized,and functioning in the human body,were chosen as the candidate compounds [18].Then, the structural and physiochemical properties of candidate compounds in HZKY were identified using the DrugBank(https://www.drugbank.ca/) database.Compounds that were drug-like (DL) ≥0.18 were identified as the main active compounds of HZKY[19,20].

    Potential target prediction of active compounds.The potential targets for active compounds in HZKY were screened using TCMSP, TCMID, Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine (BATMAN-TCM), and PUBCHEM (https://pubchem.ncbi.nlm.nih.gov)databases.The repeated targets were counted only once.

    Potential targets for prediction of the disease.Targets related to NAFLD were obtained from GeneCards (https://www.genecards.org/) and online Mendelian Inheritance in Man (OMIM)(https://www.omim.org/) databases.The protein data bank IDs for each target were imported into the Uniprot database (http://www.uniprot.org/) for standardization,and the repeated targets were removed.In addition, the potential targets of HZKY in NAFLD were identified based on the common potential targets between HZKY and NAFLD.

    Biological function and signaling pathway analysis.The Kyoto Encyclopedia of Genes and Genomes(KEGG) database was used to integrate the information and functions of potential targets.Briefly,the potential targets were analyzed and enriched in the KEGG database (https://www.kegg.jp/).KEGG terms withP<0.05 and q <0.05 were screened.

    Establishment and analysis of the compound-target-pathway network.The relationships among compounds,targets,and pathways of HZKY in NAFLD were visualized using the compound-target-pathway network using Cytoscape 3.7.2 [21].According to the compound-target-pathway network, compounds, targets, and pathways were visualized using different colors and were combined based on their potential interactions.

    Experimental Validation

    Reagents.HFD (17.7% sucrose, 17.7% fructose,19.4% protein, and 40% fat) was purchased from Beijing HFK Bioscience Co., Ltd.(Beijing, China).A BCA protein assay kit and triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol(LDL-C), and high-density lipoprotein cholesterol(HDL-C) test kits were purchased from Nanjing Jiancheng Biological Engineering Institute (Nanjing,China).Oil red O staining kit was obtained from Solarbio Biotechnology Co., Ltd.(Beijing, China).Primary antibodies against rat caspase-3 (CASP3;ab13847; 1:500), caspase-9 (CASP9; ab184786;1:1000), BAX (Bcl-2 associated X protein; ab32503;1:10000), and β-ACTIN (ab179467 1:5000) were purchased from Abcam, Inc.(Shanghai, China), and the corresponding secondary antibodies were obtained from Abcam,Inc.(Shanghai,China).

    Animals.Male Sprague-Dawley (SD) rats weighing 190-210 g, were purchased from Weitonglihua Animal Co.,Ltd.(Beijing,China).All animals were housed for 1 week in a temperature- and humidity-controlled environment (12-h light/dark cycle, 21 ± 2℃, and a relative humidity of 45 ± 10%) in groups of five rats/cage and were allowed feed and water ad libitum.

    Induction of the NAFLD model rat.The NAFLD model was induced as described previously [22].Briefly, the rats were fed with HFD diet for 12 weeks.Their body weights and serum TG, TC, LDL-C, and HDL-C levels were measured to evaluate the induction of NAFLD.In addition, H&E and oil red O staining were used to observe the pathological changes in the rat livers.All animal experiments were approved by the Institutional Animal Care and Use Committee of Tianjin University of Traditional Chinese Medicine(SYXK2019-0006) and were performed in accordance with the National Institutes of Health “Guide for the Care and Use of LaboratoryAnimals”.

    Preparation of the HZKY Test Solution.The HZKY decoction was provided by the First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine(Tianjin, China).The herbs included in the HZKY decoction were identified by the pharmacist in the pharmacy of the First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine.The water extract of HZKY was concentrated at the laboratory of Tianjin University of Traditional Chinese Medicine.Briefly, the herbs were immersed in water for 30 min(the surface of the water covered the herbs by 2-3 cm)and boiled at 100°C for 20 min using a gallipot.The liquid was then filtered through gauze.The same volume of water and herbs were boiled for another 15 min and filtered through gauze.The two filtrates were mixed to obtain the water extract of HZKY [23].The water extract of HZKY was concentrated to a density of 0.85 g crude herb/mL under decompressed distillation using a DZF-6050 vacuum drying box(Beijing SanBo Technology Co., Ltd., Beijing, China)and SENCO R rotating evaporator (Beijing Biological Innovation Technology Co.,Ltd.,Beijing,China).

    Animal grouping.After 1 week of adaptive feeding,30 rats were randomly classified into three groups:control, model, and HZKY groups.Rats in the control group were provided standard laboratory chow containing 59.4% total carbohydrate, 20% protein, and 4.8% fat.An NAFLD model rat was induced using HFD in the model and HZKY groups.Moreover, the HZKY group received an oral gavage of HZKY(8.5 g crude herb/kg rat weight) once daily for 8 weeks after 4 weeks of HFD feeding.The dosage of 8.5 g crude herb/kg in the HZKY group was equivalent to the daily dosage of HZKY in human adults, which was calculated using the following formula: equivalent dosage (g/kg) = clinical dosage of crude herbs in humans (g/kg) × 6.25.Meanwhile, the control and model group rats were given oral gavage of same volume of saline once daily for 8 weeks after 4 weeks of feeding.

    Serum biochemical marker assays.Following HZKY treatment, rats were anesthetized (chloral hydrate intraperitoneal administration,0.3 mL/100 g rat weight)after a 5-h period of fasting, and blood was harvested from the inner canthus using a capillary glass tube.Serum was obtained by centrifugation with a SW 60 Ti rotor (Beckman Coulter Inc., Palo Alto, CA) at 3000 rpm for 15 min.Serum levels of TG, TC, LDL-C, and HDL-C were measured according to the manufacturer's instructions (Nanjing Jiancheng Biological Engineering Institute, Nanjing, China), and the absorbance was detected using a Varioskan Flash microplate reader(Thermo Fisher Scientific,USA).

    In a 96-well plate, 2.5 μL of distilled water,TG and TC standards,and serum samples were mixed with 250 μL of working solution and incubated at 37°C for 10 min.The absorbance value of each pore was measured using a microplate reader at 510 nm.The derived optical density (OD) value of distilled water, TG and TC standards, and serum samples were denoted by OD1, OD2, and OD3, respectively.The TG and TC levels were calculated using the following formulae:

    In accordance with the instructions for LDL-C and HDL-C, 2.5 μL of distilled water, LDL-C and HDL-C standards,and serum samples were incubated with 180 μL of reagent R1 supplied by kit at 37°C for 5 min in 96-well plates.After determining the absorbance value of a microplate reader at 546 nm, the OD values of distilled water, standards, and serum samples were recorded as OD1, OD2and OD3, respectively.Then, 60 μL of reagent R2 was added into each well, repeating the previous step, and the mixed solution was incubated at 37℃for 5 min.The absorbance value was detected by microplate reader at 546 nm.The OD values of distilled water,standards,and serum samples were recorded as OD1', OD2', and OD3', respectively.The LDL-C and HDL-C levels were obtained using the following formulae:

    H&E staining.Rats were sacrificed after blood collection.The liver was immediately removed and fixed with 10%formalin,dehydrated,and embedded in paraffin wax.It was then cut into 5-μm sections using a slicing machine (RM2125, Leica, Buffalo Grove,USA) at the laboratory at Tianjin University of Traditional Chinese Medicine.Sections were stained with H&E as described previously [24].Briefly, after dewaxing, rehydration, staining, dehydration,transparency, and sealing, the pathological changes in the liver were visualized under a light microscope(BX50,Olympus America,Melville,NY,USA).

    Oil red O staining.Fresh liver tissue was rapidly frozen in liquid nitrogen and sectioned using a frozen slicer (CM3050S, Leica, Buffalo Grove, USA) to obtain coronal cryostat sections (10-μm thick).The sections were then dried at room temperature for 5 min.Next, the sections were stained with oil red O according to the manufacturer's instructions (Solarbio Biotechnology Co., Ltd., Beijing, China).Briefly, the sections were stained with oil red O lipid staining working buffer for 45 min after fixing with 5%formaldehyde solution, washed with 60% isopropanol five times, and subsequently washed with distilled water for 2 min.Sections were stained again with hematoxylin for 2 min, washed with distilled water for 5 min, and dried and sealed with glycerine.They were then immediately photographed under a light microscope (BX50, Olympus America, Melville, NY,USA).

    Western blotting analysis.The liver samples were homogenized with whole lysis buffer to extract proteins from the liver.Then,a BCA protein assay was used to quantify and standardize the proteins.Electrophoresis (8-12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis) was used to isolate the proteins, which were transferred onto a polyvinylidene difluoride membrane for Western blotting.The membrane was then sealed with 5% milk and incubated overnight with primary antibodies(rabbit anti-CASP1,1:500;rabbit anti-CASP9, 1:1000;rabbit anti-BAX, 1:10000; and rabbit anti-β-ACTIN,1:10000) at 4℃.After incubation for 1 hour, TBST was used to clean the membrane, and the secondary antibody probe (HRP combined with goat anti-rabbit IgG, 1:4000) was used for detection.Blotting was observed using chemiluminescence (TanonTMHigh-sig ECL, Li COR, USA).The strip strength was quantitatively analyzed using Image J software (NIH,Bethesda,MD,USA).

    Data Analysis.All values were reported as the mean±standard deviation (mean ± SD).SPSS software version 20.0 was used for single factor analysis of variance, and the statistical significance standard wasP<0.05.

    Results

    Results of Network Pharmacology

    Main active compounds in HZKY.The 924 compounds present in HZKY, including 65 from Zhishi (Aurantii Fructus Immaturus), 60 from Peilan(Eupatorii Herba), 58 from Huangqin (Scutellariae Radix), 93 from Heye (Nelumbinis Folium), 92 from Dahuang (Rhei Radix et Rhizoma), 75 from Shaoyao(Paeoniae Radix Rubra), 288 from Chaihu (Bupleuri Radix), 77 from Bohe (Menthae Haplocalycis Herba),and 116 from Banxia (Pinelliae Rhizoma), were screened using the TCMSP and TCMID.A total of 130 active compounds, including 22 from Zhishi (Aurantii Fructus Immaturus),11 from Peilan(Eupatorii Herba),24 from Huangqin (Scutellariae Radix), 15 from Heye(Nelumbinis Folium), 16 from Dahuang (Rhei Radix et Rhizoma), 27 from Shaoyao (Paeoniae Radix Rubra),17 from Chaihu (Bupleuri Radix), 10 from Bohe(Menthae Haplocalycis Herba), and 36 from Banxia(Pinelliae Rhizoma), were identified with OB ≥ 30%and DL ≥ 0.18.The structure and physiochemical properties of the compounds are listed in Table 1.

    Table 1 List of active candidate components in HZKY

    Table 1 List of active candidate components in HZKY(Continued)

    Table 1 List of active candidate components in HZKY(Continued)

    Potential targets of active compounds in HZKY.A total of 1,672 targets were obtained from 130 active compounds in HZKY based on the TCMSP, TCMID,Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine, and PUBCHEM databases.Repeated targets were removed,and 269 targets were identified with alignment from the Uniprot database.

    Identification of potential targets and pathways of HZKY in NAFLD and network analysis of compounds, targets, and pathways.A total of 1,334 targets for NAFLD were identified from the online Mendelian Inheritance in Man and GeneCards databases.After intersecting with 269 targets of HZKY,62 targeted were identified as potential targets of HZKY in NAFLD.

    The interactive relationship of 62 potential targets was analyzed and visualized using String 11.0.The candidates with the highest values of network connectivity were BAX, CASP3, CASP9, IL6, EGFR,MAPK8, CYCS, ESR1, VEGFA, LDLR, PPARG,PLAU, VCAM1, CYP3A4, GSK3B, PON1, GSTP1,NQO1, CTSD, and ACACA.BAX, CASP3, and CASP9 were the targets with the highest values of network connectivity.Additionally, as determined using KEGG analysis, apoptosis, fatty acid synthesis,and estrogen signaling pathways were the terms with the highest network connectivity.

    The compounds, targets, and pathways of HZKY in NAFLD were imported into Cytoscape 3.7.2 to establish the compound-target-pathway network(Figure 1).

    According to the compound-target-pathway network,compounds targeted to BAX included M56, M95, and M116; compounds targeted to CASP9 included M1,M2, M3, M5, M8, M9, M10, M13, M14, M21, M25,M29, M31, M33, M34, M35, M39, M49, M50, M57,M59, M62, and M125; and compounds targeted to CASP3 included M1, M2, M3, M4, M5, M6, M8, M9,M10, M14, M13, M19, M21, M23, M25, M33, M34,M35, M38, M39, M49, M50, M56, M57, M58, M59,M62,M64,M65,M84,M95,M116,M125,and M130.Moreover, BAX, CASP9, and CASP3 are closely associated with the apoptosis pathway.Therefore, the apoptosis pathway was predicted to be the potential mechanism of action of HZKY in NAFLD.

    Results of Experimental Validation

    HZKY ameliorated HFD-induced NAFLD in rats.Using the NAFLD model rat, we observed that 12 weeks of HFD led to a significant increase in body weight in the model group compared with that in the control group (467.07 ± 15.31 vs.414.29 ± 28.93 g,P< 0.01), whereas HZKY treatment significantly decreased the body weight in the HZKY group compared with that in the model group (420.57 ±15.52 vs.467.07 ± 15.31 g,P<0.01, Table 2).In addition,the serum levels of TG,TC,and LDL-C were significantly elevated and the serum level of HDL-C was decreased in the model group compared with that in the control group (TG: 1.70 ± 0.13 vs.0.28 ± 0.04,TC: 2.58 ± 0.34 vs.1.40 ± 0.26, LDL-C: 1.50 ± 0.23 vs.0.89 ± 0.09, and HDL-C: 1.29 ± 0.16 vs.1.86 ±0.18,P<0.01 for all, Table 2).HZKY treatment decreased the serum levels of TG,TC, and LDL-C and increased the serum level of HDL in the HZKY group compared with those in the model group (TC: 2.16 ±0.22 vs.2.58±0.34,P<0.01;TG:1.28±0.16 vs.1.70± 0.13,P<0.05; LDL-C: 1.14 ± 0.22 vs.1.50 ± 0.23,P<0.05;and HDL-C:1.49±0.14 vs.1.29±0.16,P<0.05,Table 2).

    H&E staining demonstrated that the hepatic lobule and nucleus were clearly visible, the sizes of the hepatocytes were similar, and the hepatic cord was arranged neatly in the control group.Compared with that in the control group, in the model group, hepatic steatosis was obvious, indicating that there were vacuolar adipose droplets of various sizes and more balloon-like changes in hepatocytes, and the structure of the hepatic tissue could not be clearly observed.HZKY treatment markedly alleviated the hepatic steatosis and balloon-like changes in the HZKY group compared with that in the model group(Figure 2a).

    Similarly, oil red O staining revealed that slight lipid deposition was observed in the control group.The lipid droplets in the cytoplasm of hepatocytes were stained red and were of various sizes and widely distributed in the cytoplasm, indicating the presence of lipid deposition in a large number of hepatocytes.However,HZKY significantly ameliorated lipid deposition and reduced the number of intracellular lipid droplets(Figure 2b).

    Figure 1 Compound-target-pathway network.The blue nodes represent the targets, the yellow nodes represent the active components of HZKY,and the red nodes represent pathways.Every active ingredient can act on multiple targets.

    Table 2 HZKY treatment decreased body weight and changed the blood lipid composition in NAFLD model rats.

    HZKY inhibited apoptosis in NAFLD model rats

    According to pathways identified from the network pharmacology, apoptosis was selected as the mechanism for HZKY in NAFLD.Expressions of BAX, CASP9, and CASP3, which were predicted as the top targets of HZKY in NAFLD, were investigated to determine the anti-apoptotic activities of HZKY in NAFLD.The expressions of BAX, CASP9, and CASP3 were elevated in the model group compared with those in the control group(for BAX,P<0.05;for CASP9 and CASP3,P<0.01; Figure 3), whereas HZKY treatment decreased the expressions of BAX,CASP9, and CASP3 in the HZKY group compared with those the model group(for BAX and CASP9,P<0.05;for CASP3,P<0.01;Figure 3).

    Discussions

    In this study,the potential targets of HZKY in NAFLD were predicted using network pharmacology.Many compounds in HZKY, such as baicalein,o-nornuciferine, and quercetin, have been demonstrated to have treatment effects in NAFLD.Baicalein, derived from Banxia (Pinelliae Rhizoma),Huangqin (Scutellariae Radix), and Shaoyao(Paeoniae Radix Alba), is shown to reduce lipid accumulation in NAFLD model rats by inhibiting oxidative stress [25].O-Nornuciferine, derived from Heye (Nelumbinis Folium), decreases the serum TG and TC levels in NAFLD mouse models [26].Quercetin, derived from Chaihu (Bupleuri Radix) and Heye (Nelumbinis Folium), improves NAFLD via downregulation of FAS and SREBP-1C expression and upregulation of IRS1 expression in the liver [27].In addition, BAX, CASP9, and CASP3 were the HZKY targets with the highest values of network connectivity,and apoptosis was the main signaling pathway of HZKY in NAFLD.The effects of HZKY in NAFLD model rats were also investigated in the present study.The results showed that HZKY treatment significantly improved the serum levels of TG, TC, LDL-C, and HDL-C in NAFLD model rats.Moreover, lipid accumulation in the liver was reduced following HZKY treatment, indicating the significant curative effect of HZKY in NAFLD.

    NAFLD is accompanied by the apoptosis of hepatocytes [28]; electron microscopy previously showed that the ultrastructures of mitochondria were damaged in the hepatocytes of patients with NAFLD[29].Steatosis in hepatocytes can impair the function and decrease the membrane potential of mitochondria.A decrease in the mitochondrial membrane potential can trigger the release of cytochrome C and activate caspase family proteins, ultimately inducing apoptosis of hepatocytes [30].Furthermore, dysfunction in fatty acid synthesis can cause obesity and NAFLD.The uptake and synthesis of fatty acids in the liver is significantly increased in the liver [31].Excessive amounts of fatty acid can trigger IR by inducing oxidative stress and decreasing sensitivity in hepatocytes.IR can cause dysfunction of lipase activity,thereby triggering lipolysis in the peripheral organs and increasing the levels of fatty acids in the serum[32].Moreover,IR induces hyperinsulinemia, and high levels of insulin inhibit the β-oxidation of fatty acids.The excess fatty acids can be transported to the liver and cause steatosis in hepatocytes and NAFLD [33].Estrogen has also been demonstrated to be associated with NAFLD.Compared with premenopausal women,postmenopausal women exhibit an increase in body weight, lipid accumulation, hepatic inflammatory responses, and oxidative stress [34].The activation of estrogen receptors can increase the production of bile acid in NAFLD model mice.Bile acid can activate the farnesoid X receptor to inhibit lipogenesis in the liver.Estrogen receptors can also directly reduce the lipid contents and liver injury in NAFLD model mice by inhibiting the activation of pregnane X receptor.Estrogen can also improve NAFLD by regulating the TLR-MYD88-IL-6 pathway.Estrogen has been demonstrated to improve hepatocyte injury in NAFLD by inhibiting the activation of NF-κB and C/EBPβ and decreasing the activity of IL-6 promoter [35] .In addition, lack of estrogen can contribute to the progression of NAFLD[36-37].BAX,CASP9, and CASP3 are important factors that modulate apoptosis in NAFLD.Accumulation of free fatty acids is shown to activate and dimerize BAX in the cytoplasm [38].Dimerized BAX is transported to the outer membrane of the mitochondria and activates CASP-9 and CASP-3 to initiate apoptosis[39].

    Given the high correlation of the apoptotic pathway predicted by network pharmacology, we determined the anti-apoptotic activities of HZKY in NAFLD model rats.In agreement with the results of network pharmacology analysis, our results show that HZKY treatment significantly decrease the levels of apoptosis-related proteins, including BAX, CASP9,and CASP3,in the liver.

    Figure 2 Hepatic steatosis was improved after HZKY treatment.

    Figure 3 HZKY treatment regulated the expressions of BAX,CASP9 and CASP3 in NAFLD model rats.

    Conclusion

    The present study demonstrates that HZKY improves NAFLD by inhibiting apoptosis in the liver by decreasing the levels of apoptosis-related proteins,including BAX,CASP9,and CASP3.

    男人的好看免费观看在线视频| 狠狠狠狠99中文字幕| 婷婷色综合大香蕉| 成人毛片a级毛片在线播放| 国产真实乱freesex| 亚洲中文日韩欧美视频| aaaaa片日本免费| 国产女主播在线喷水免费视频网站 | 少妇被粗大猛烈的视频| 亚洲精品一卡2卡三卡4卡5卡| 男女那种视频在线观看| 久久久久久久精品吃奶| 成年人黄色毛片网站| 欧美日韩瑟瑟在线播放| 久久精品国产亚洲网站| 伦精品一区二区三区| 国产淫片久久久久久久久| 国产一区二区三区在线臀色熟女| 在线观看免费视频日本深夜| 特大巨黑吊av在线直播| 精品免费久久久久久久清纯| 女生性感内裤真人,穿戴方法视频| 深夜a级毛片| 亚洲最大成人中文| a级一级毛片免费在线观看| 国产成人a区在线观看| 国内精品久久久久精免费| 亚洲无线在线观看| 中国美白少妇内射xxxbb| 少妇人妻精品综合一区二区 | 亚洲最大成人手机在线| 美女黄网站色视频| 久久亚洲精品不卡| 欧美最新免费一区二区三区| 精品久久久久久久久久免费视频| 久久草成人影院| 熟女人妻精品中文字幕| 69人妻影院| 久久精品国产亚洲av涩爱 | 深夜a级毛片| 亚洲经典国产精华液单| 男人狂女人下面高潮的视频| 亚洲va在线va天堂va国产| a级毛片a级免费在线| 亚洲国产精品sss在线观看| 国产一级毛片七仙女欲春2| 中国美白少妇内射xxxbb| 特大巨黑吊av在线直播| 精品人妻熟女av久视频| 欧美一区二区亚洲| 亚洲成人中文字幕在线播放| 三级男女做爰猛烈吃奶摸视频| 日日夜夜操网爽| 久久99热6这里只有精品| 18禁裸乳无遮挡免费网站照片| 成年女人永久免费观看视频| av国产免费在线观看| 三级国产精品欧美在线观看| 午夜日韩欧美国产| 欧美国产日韩亚洲一区| 春色校园在线视频观看| 美女xxoo啪啪120秒动态图| 欧美激情久久久久久爽电影| 毛片女人毛片| 亚洲av一区综合| 成人国产一区最新在线观看| 亚洲三级黄色毛片| 一卡2卡三卡四卡精品乱码亚洲| 亚洲欧美精品综合久久99| 久久草成人影院| 夜夜夜夜夜久久久久| 国产乱人视频| 国产在视频线在精品| 欧美xxxx性猛交bbbb| 国产成人av教育| 精品人妻熟女av久视频| 成人性生交大片免费视频hd| 亚洲精华国产精华精| 少妇高潮的动态图| 免费在线观看日本一区| 中文字幕免费在线视频6| 又黄又爽又刺激的免费视频.| 免费人成在线观看视频色| 可以在线观看的亚洲视频| 两个人视频免费观看高清| 日日撸夜夜添| 国产一区二区三区av在线 | 琪琪午夜伦伦电影理论片6080| 18禁黄网站禁片免费观看直播| 亚洲一级一片aⅴ在线观看| 久久精品国产亚洲av涩爱 | 永久网站在线| 伊人久久精品亚洲午夜| 色综合婷婷激情| 免费人成在线观看视频色| 老师上课跳d突然被开到最大视频| 51国产日韩欧美| 简卡轻食公司| 亚洲人成伊人成综合网2020| av在线天堂中文字幕| 国产精品,欧美在线| 美女免费视频网站| 悠悠久久av| 欧美区成人在线视频| 亚洲国产日韩欧美精品在线观看| 成人av在线播放网站| 久久久久久久精品吃奶| 精品一区二区免费观看| 国产一区二区三区视频了| 中文字幕免费在线视频6| 亚洲欧美激情综合另类| 精品一区二区三区视频在线| 色精品久久人妻99蜜桃| а√天堂www在线а√下载| 亚洲国产欧美人成| 久久久久久大精品| 色吧在线观看| 精华霜和精华液先用哪个| 91麻豆精品激情在线观看国产| 亚洲av.av天堂| 色哟哟哟哟哟哟| 欧美人与善性xxx| 天堂网av新在线| 久久久久久久久中文| 日韩国内少妇激情av| 国产熟女欧美一区二区| 成人综合一区亚洲| 淫妇啪啪啪对白视频| 亚洲av中文字字幕乱码综合| 国产精品99久久久久久久久| 亚洲av二区三区四区| 天堂网av新在线| 欧美性猛交黑人性爽| 黄片wwwwww| 黄色女人牲交| 久久久久久大精品| 亚洲av一区综合| 国产私拍福利视频在线观看| 五月玫瑰六月丁香| 成年女人永久免费观看视频| 亚洲综合色惰| 成人国产麻豆网| 亚洲国产欧洲综合997久久,| 日韩强制内射视频| 亚洲国产欧美人成| av在线蜜桃| 欧美最新免费一区二区三区| 在线观看av片永久免费下载| 国产男靠女视频免费网站| 久久精品91蜜桃| 天堂av国产一区二区熟女人妻| 国产在视频线在精品| 又黄又爽又刺激的免费视频.| 欧美一级a爱片免费观看看| 国产 一区 欧美 日韩| 99久久成人亚洲精品观看| 真人一进一出gif抽搐免费| 最后的刺客免费高清国语| 亚洲精品影视一区二区三区av| a级毛片免费高清观看在线播放| 热99在线观看视频| 特级一级黄色大片| 看片在线看免费视频| 国产成人a区在线观看| 国产成人a区在线观看| 大又大粗又爽又黄少妇毛片口| 亚洲av成人精品一区久久| 中文字幕久久专区| 欧美一级a爱片免费观看看| 成人综合一区亚洲| 成人欧美大片| 看黄色毛片网站| 伦精品一区二区三区| 在线国产一区二区在线| 午夜精品一区二区三区免费看| 国内精品久久久久精免费| 国产探花极品一区二区| 少妇的逼水好多| 美女被艹到高潮喷水动态| 波多野结衣巨乳人妻| 国产精品乱码一区二三区的特点| 全区人妻精品视频| 日日啪夜夜撸| 国产精品久久视频播放| 露出奶头的视频| 成人午夜高清在线视频| 一本一本综合久久| 精品久久久久久成人av| 国产欧美日韩精品一区二区| 久久久久久久亚洲中文字幕| 真人一进一出gif抽搐免费| 91在线精品国自产拍蜜月| 国产欧美日韩精品亚洲av| 岛国在线免费视频观看| 乱系列少妇在线播放| 亚洲不卡免费看| 能在线免费观看的黄片| 色av中文字幕| 日日摸夜夜添夜夜添小说| 亚洲精华国产精华液的使用体验 | 午夜福利18| 国产国拍精品亚洲av在线观看| а√天堂www在线а√下载| 国产精品女同一区二区软件 | 日本三级黄在线观看| 男女那种视频在线观看| 精品福利观看| 国产乱人视频| 一个人看的www免费观看视频| 中文亚洲av片在线观看爽| 亚洲精品在线观看二区| av国产免费在线观看| 丰满人妻一区二区三区视频av| 舔av片在线| 69人妻影院| 亚洲四区av| 午夜激情欧美在线| 国产麻豆成人av免费视频| 欧美中文日本在线观看视频| 别揉我奶头 嗯啊视频| 欧美国产日韩亚洲一区| 最近最新中文字幕大全电影3| 大又大粗又爽又黄少妇毛片口| 在线观看舔阴道视频| 国产精品国产高清国产av| 亚洲电影在线观看av| 嫩草影视91久久| 精品人妻1区二区| 男女下面进入的视频免费午夜| 香蕉av资源在线| 九九热线精品视视频播放| 一夜夜www| 精品久久久久久久末码| 久久99热6这里只有精品| 欧美另类亚洲清纯唯美| 国产激情偷乱视频一区二区| 亚洲第一区二区三区不卡| 亚洲精品亚洲一区二区| 精品人妻熟女av久视频| 欧美不卡视频在线免费观看| 欧美一区二区国产精品久久精品| 欧美高清性xxxxhd video| 日韩一本色道免费dvd| 日本爱情动作片www.在线观看 | 永久网站在线| 中亚洲国语对白在线视频| av专区在线播放| 国产主播在线观看一区二区| 国产视频内射| 国产一区二区三区视频了| 日本a在线网址| 国产精品电影一区二区三区| 色综合亚洲欧美另类图片| 在线看三级毛片| 成年女人看的毛片在线观看| 欧美在线一区亚洲| 尾随美女入室| 欧美一区二区国产精品久久精品| 精品一区二区三区av网在线观看| 国产精品久久久久久精品电影| 99热这里只有是精品在线观看| 国产亚洲精品久久久久久毛片| 制服丝袜大香蕉在线| 国产探花在线观看一区二区| 精品乱码久久久久久99久播| 国内久久婷婷六月综合欲色啪| 欧美一区二区亚洲| 成人一区二区视频在线观看| 免费av毛片视频| 性欧美人与动物交配| 国语自产精品视频在线第100页| 一进一出抽搐动态| 久久精品国产亚洲网站| 久久久久久久久久成人| av国产免费在线观看| 啪啪无遮挡十八禁网站| 国内久久婷婷六月综合欲色啪| 熟女电影av网| 国产亚洲91精品色在线| 久99久视频精品免费| 尤物成人国产欧美一区二区三区| 国产老妇女一区| 久久精品国产亚洲av香蕉五月| 欧美成人性av电影在线观看| 18禁黄网站禁片午夜丰满| 精品一区二区三区av网在线观看| 国产极品精品免费视频能看的| 日本精品一区二区三区蜜桃| 久久天躁狠狠躁夜夜2o2o| 成熟少妇高潮喷水视频| 国产精品人妻久久久久久| 成年女人看的毛片在线观看| 久久精品国产自在天天线| 十八禁网站免费在线| 色播亚洲综合网| 在线免费观看不下载黄p国产 | 此物有八面人人有两片| 日韩欧美一区二区三区在线观看| 男女之事视频高清在线观看| 免费在线观看成人毛片| 国内久久婷婷六月综合欲色啪| 内射极品少妇av片p| 久久欧美精品欧美久久欧美| 久久久久久久久久黄片| 日韩欧美精品免费久久| 日本在线视频免费播放| 熟妇人妻久久中文字幕3abv| www日本黄色视频网| 在线播放无遮挡| 天堂动漫精品| 色尼玛亚洲综合影院| 久久国产乱子免费精品| 欧美中文日本在线观看视频| 午夜影院日韩av| 熟女人妻精品中文字幕| 日韩中文字幕欧美一区二区| 亚洲va在线va天堂va国产| 少妇高潮的动态图| 狠狠狠狠99中文字幕| netflix在线观看网站| 天堂动漫精品| 午夜精品一区二区三区免费看| 国产免费av片在线观看野外av| 免费在线观看成人毛片| 人人妻,人人澡人人爽秒播| 别揉我奶头~嗯~啊~动态视频| av.在线天堂| 午夜福利在线观看吧| 舔av片在线| or卡值多少钱| 亚洲精品国产成人久久av| 18禁在线播放成人免费| 1024手机看黄色片| 亚洲图色成人| 日本黄色视频三级网站网址| 国产私拍福利视频在线观看| 成人午夜高清在线视频| 亚洲精品乱码久久久v下载方式| 国产精品99久久久久久久久| 亚洲精品日韩av片在线观看| 色播亚洲综合网| 内地一区二区视频在线| 欧美激情久久久久久爽电影| 亚洲精品一区av在线观看| 日韩av在线大香蕉| 欧美高清性xxxxhd video| 亚洲经典国产精华液单| 久久中文看片网| 俺也久久电影网| 中出人妻视频一区二区| 国产av麻豆久久久久久久| 久久精品国产99精品国产亚洲性色| 国产精品1区2区在线观看.| 日韩强制内射视频| 蜜桃亚洲精品一区二区三区| 亚洲第一区二区三区不卡| 91在线精品国自产拍蜜月| 99久久精品一区二区三区| av中文乱码字幕在线| 国产亚洲精品久久久com| 欧美激情国产日韩精品一区| 久久精品久久久久久噜噜老黄 | 国产精华一区二区三区| 99久久精品一区二区三区| av国产免费在线观看| 亚洲欧美日韩高清专用| 伦精品一区二区三区| 精品久久久久久久久亚洲 | 网址你懂的国产日韩在线| 亚洲一区二区三区色噜噜| 欧美日本亚洲视频在线播放| 国产一区二区在线av高清观看| 99热这里只有是精品在线观看| 亚洲va日本ⅴa欧美va伊人久久| 日本与韩国留学比较| 亚洲无线在线观看| 久久久色成人| 午夜免费男女啪啪视频观看 | 国产精品国产高清国产av| 黄色女人牲交| 午夜精品在线福利| 国产 一区 欧美 日韩| 啦啦啦啦在线视频资源| 麻豆成人av在线观看| or卡值多少钱| 亚洲精品乱码久久久v下载方式| 国内少妇人妻偷人精品xxx网站| 色精品久久人妻99蜜桃| 国产午夜精品论理片| 波多野结衣高清作品| 亚洲av电影不卡..在线观看| 亚洲成人免费电影在线观看| 69人妻影院| 国产激情偷乱视频一区二区| 婷婷六月久久综合丁香| 欧美丝袜亚洲另类 | 99久久中文字幕三级久久日本| 欧美色欧美亚洲另类二区| 一个人看视频在线观看www免费| 日韩欧美一区二区三区在线观看| 很黄的视频免费| 国产精品亚洲美女久久久| 国产一区二区在线观看日韩| 日本熟妇午夜| av在线观看视频网站免费| 国产黄色小视频在线观看| 久久久久性生活片| 久久久久久久久中文| 自拍偷自拍亚洲精品老妇| 国产av不卡久久| 国产精品日韩av在线免费观看| 无人区码免费观看不卡| 亚洲第一区二区三区不卡| 精品免费久久久久久久清纯| 真实男女啪啪啪动态图| 嫩草影视91久久| 俺也久久电影网| 天天一区二区日本电影三级| 国产欧美日韩精品亚洲av| 麻豆av噜噜一区二区三区| 国产午夜福利久久久久久| 亚洲性夜色夜夜综合| 91麻豆av在线| 国产亚洲精品久久久久久毛片| 成年女人永久免费观看视频| 国产视频内射| 国产老妇女一区| 哪里可以看免费的av片| 精品午夜福利视频在线观看一区| 人妻夜夜爽99麻豆av| 日本a在线网址| 国产综合懂色| 亚洲真实伦在线观看| 最近中文字幕高清免费大全6 | 亚洲三级黄色毛片| 亚洲自拍偷在线| 久久九九热精品免费| 在线观看舔阴道视频| 精品一区二区免费观看| 免费在线观看成人毛片| 国产精品98久久久久久宅男小说| 久久久久久久午夜电影| 亚洲第一电影网av| 久久久午夜欧美精品| 国产伦一二天堂av在线观看| 搡女人真爽免费视频火全软件 | 亚洲成人精品中文字幕电影| 中亚洲国语对白在线视频| av专区在线播放| 国产高清激情床上av| 韩国av在线不卡| 999久久久精品免费观看国产| 超碰av人人做人人爽久久| 国产主播在线观看一区二区| 亚洲av.av天堂| 天堂影院成人在线观看| 高清日韩中文字幕在线| 日本一本二区三区精品| a级毛片a级免费在线| 欧美激情国产日韩精品一区| 中亚洲国语对白在线视频| 动漫黄色视频在线观看| 国产精品美女特级片免费视频播放器| 精品久久久久久,| 国产久久久一区二区三区| 高清日韩中文字幕在线| 免费一级毛片在线播放高清视频| 极品教师在线免费播放| 国产精品98久久久久久宅男小说| 亚洲欧美日韩高清专用| 亚洲美女黄片视频| 亚洲天堂国产精品一区在线| 综合色av麻豆| 国产毛片a区久久久久| 在线观看午夜福利视频| 亚洲av二区三区四区| 亚洲精品国产成人久久av| 欧美性感艳星| 99精品在免费线老司机午夜| 在线观看一区二区三区| 国产成人aa在线观看| 免费观看在线日韩| 99久久精品国产国产毛片| 国产老妇女一区| 亚洲精品久久国产高清桃花| 成人特级av手机在线观看| 欧美一级a爱片免费观看看| 亚洲综合色惰| 欧美另类亚洲清纯唯美| 日韩一本色道免费dvd| 能在线免费观看的黄片| 国产精品综合久久久久久久免费| a在线观看视频网站| 国产成人aa在线观看| 亚洲第一电影网av| 99国产极品粉嫩在线观看| 亚洲四区av| 又黄又爽又免费观看的视频| 有码 亚洲区| 成人美女网站在线观看视频| 色综合亚洲欧美另类图片| 亚洲男人的天堂狠狠| av在线观看视频网站免费| 韩国av在线不卡| 在线观看一区二区三区| 国产欧美日韩精品一区二区| 久久久久久久精品吃奶| 老熟妇仑乱视频hdxx| 精品日产1卡2卡| 波多野结衣高清作品| 熟妇人妻久久中文字幕3abv| 亚洲最大成人手机在线| 国产一区二区三区av在线 | 禁无遮挡网站| 国产精品无大码| 观看免费一级毛片| 免费大片18禁| 亚洲国产高清在线一区二区三| xxxwww97欧美| 国产精品国产三级国产av玫瑰| 在线观看舔阴道视频| 最后的刺客免费高清国语| 99国产极品粉嫩在线观看| 亚洲第一电影网av| 中文字幕熟女人妻在线| 变态另类成人亚洲欧美熟女| 韩国av在线不卡| 亚洲综合色惰| 亚洲国产日韩欧美精品在线观看| 俺也久久电影网| 午夜影院日韩av| 亚洲人成网站高清观看| 国产黄色小视频在线观看| 国产一级毛片七仙女欲春2| 免费看日本二区| 波多野结衣高清作品| 亚洲欧美日韩东京热| 成年人黄色毛片网站| 亚洲精品日韩av片在线观看| 联通29元200g的流量卡| 免费搜索国产男女视频| 亚洲av中文av极速乱 | 床上黄色一级片| 白带黄色成豆腐渣| 中文字幕精品亚洲无线码一区| 国产免费av片在线观看野外av| 免费av观看视频| 亚洲va在线va天堂va国产| 国产精品福利在线免费观看| 淫妇啪啪啪对白视频| 一个人免费在线观看电影| av在线蜜桃| 中文字幕免费在线视频6| 国产精品日韩av在线免费观看| 波野结衣二区三区在线| 欧美色欧美亚洲另类二区| 亚洲一级一片aⅴ在线观看| 熟妇人妻久久中文字幕3abv| 99在线视频只有这里精品首页| 欧美bdsm另类| 午夜免费男女啪啪视频观看 | 精品久久久久久久久久免费视频| 国产精品精品国产色婷婷| 日本黄色视频三级网站网址| 美女高潮的动态| 欧美精品国产亚洲| 亚洲色图av天堂| 熟女人妻精品中文字幕| 国产精品久久久久久精品电影| 搡老熟女国产l中国老女人| 亚洲四区av| 久久精品久久久久久噜噜老黄 | 一区二区三区免费毛片| 最近在线观看免费完整版| 久久国产乱子免费精品| 免费在线观看日本一区| 欧美黑人巨大hd| 日本五十路高清| 真实男女啪啪啪动态图| 一区二区三区四区激情视频 | 国内精品美女久久久久久| 亚洲av电影不卡..在线观看| 综合色av麻豆| .国产精品久久| 人妻少妇偷人精品九色| 无遮挡黄片免费观看| 日本在线视频免费播放| 老熟妇乱子伦视频在线观看| 色综合站精品国产| 国产伦在线观看视频一区| 免费搜索国产男女视频| 在线a可以看的网站| 真人一进一出gif抽搐免费| 99国产极品粉嫩在线观看| 亚洲久久久久久中文字幕| 美女高潮喷水抽搐中文字幕| 欧美最黄视频在线播放免费| 麻豆国产97在线/欧美| 欧美人与善性xxx| 午夜福利在线观看吧| 国产极品精品免费视频能看的| 国产中年淑女户外野战色| 亚洲成人精品中文字幕电影| 亚洲成a人片在线一区二区| 少妇的逼水好多| 免费av不卡在线播放| 免费观看的影片在线观看| 波多野结衣高清无吗| 亚洲第一电影网av| 国产精品日韩av在线免费观看| 中国美白少妇内射xxxbb| 色播亚洲综合网| 日韩欧美 国产精品| 欧美丝袜亚洲另类 | 啦啦啦啦在线视频资源|